LNTH FY 2025 Earnings — Lantheus Holdings, Inc. Revenue & Financial Results | Market Cap Arena

LNTHLantheus Holdings, Inc.

$6B

FY 2025 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$1.5B+0.5% YoY

Gross Profit

$942M61.1% margin

Operating Income

$311M20.2% margin

Net Income

$234M15.2% margin

EPS (Diluted)

$3.41

Cash Flow

Operating Cash Flow

$390M

Free Cash Flow

$354M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$2.2B

Total Liabilities

$1.1B

Stockholders' Equity

$1.1B

Cash & Equivalents

$359M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.5B	$1.5B	+0.5%
Gross Profit	$942M	$988M	-4.7%
Operating Income	$311M	$457M	-32.0%
Net Income	$234M	$312M	-25.2%